Evogene Ltd. (EVGN)
0.3822
-0.02
(-4.09%)
USD |
NASDAQ |
Oct 09, 16:00
0.3907
+0.01
(+2.22%)
After-Hours: 20:00
Evogene Gross Profit Margin (Quarterly) : -2.31% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.31% |
| March 31, 2026 | 0.60% |
| December 31, 2025 | -16.88% |
| September 30, 2025 | -40.38% |
| June 30, 2025 | 28.65% |
| March 31, 2025 | 22.02% |
| December 31, 2024 | 26.57% |
| September 30, 2024 | 28.10% |
| June 30, 2024 | -10.08% |
| March 31, 2024 | 76.59% |
| December 31, 2023 | -83.56% |
| September 30, 2023 | 68.89% |
| June 30, 2023 | -69.42% |
| March 31, 2023 | -50.23% |
| December 31, 2022 | -52.27% |
| September 30, 2022 | -64.16% |
| June 30, 2022 | -180.4% |
| March 31, 2022 | -256.1% |
| December 31, 2021 | -163.3% |
| September 30, 2021 | -329.8% |
| June 30, 2021 | -420.0% |
| March 31, 2021 | -149.5% |
| December 31, 2020 | -177.5% |
| September 30, 2020 | -150.9% |
| June 30, 2020 | -182.9% |
| Date | Value |
|---|---|
| March 31, 2020 | -822.7% |
| December 31, 2019 | -546.6% |
| September 30, 2019 | -792.8% |
| June 30, 2019 | -305.2% |
| March 31, 2019 | -103.7% |
| December 31, 2018 | 1.26% |
| September 30, 2018 | -93.79% |
| June 30, 2018 | -84.51% |
| March 31, 2018 | -94.15% |
| December 31, 2017 | 13.62% |
| September 30, 2017 | 27.01% |
| June 30, 2017 | 13.58% |
| March 31, 2017 | 10.26% |
| December 31, 2016 | 4.15% |
| September 30, 2016 | 7.68% |
| June 30, 2016 | 12.89% |
| March 31, 2016 | 24.85% |
| December 31, 2015 | 18.55% |
| September 30, 2015 | 24.84% |
| June 30, 2015 | 27.26% |
| March 31, 2015 | 32.25% |
| December 31, 2014 | 34.51% |
| September 30, 2014 | 26.14% |
| June 30, 2014 | 37.01% |
| March 31, 2014 | 33.55% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Compugen Ltd. | -3.54% |
| Pluri, Inc. | 21.49% |
| Scinai Immunotherapeutics Ltd. | -272.2% |
| CollPlant Biotechnologies Ltd. | -604.6% |
| Regentis Biomaterials Ltd. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -140.6% |
| Return on Assets | -69.85% |
| Return on Invested Capital | -116.4% |
| Profit Margin (Quarterly) | -458.5% |
| Operating Margin (Quarterly) | -703.5% |
| Return on Net Operating Assets | -358.8% |